Poland – Antineoplastic agents – Oncological and auxiliary drugs
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
1) lot no. 1 – doxorubicini hydrochloridum 2) part no. 2 – ifosfamide 3) part no. 3 – mesna 4) part no. 4 – methotrexate solution 5) part no. 5 – methotrexate tablets 6) lot no. 6 – docetaxelum 7) part no. 7 – dacarbazine 8) part no. 8 – vinblastine 9) part no. 9 – vincristine 10) lot no. 10 – bleomycin 11) lot no. 11 – mitomycin 12) part no. 12 – palbociclib 13) part no. 13 – cyclophosphamide 14) part no. 14 – cyclophosphamide dragees 15) lot no. 15 – melphalan 16) lot no. 16 – chlorambucil 17) part no. 17 – fluorouracilum* 18) lot no. 18 – bicalutamide 19) part no. 19 –